Company Filing History:
Years Active: 2006-2009
Title: Changyu Zheng: Innovator in Gene Therapy
Introduction
Changyu Zheng is a prominent inventor based in Rockville, MD (US), known for his significant contributions to the field of gene therapy. He holds a total of 3 patents that focus on innovative methods for gene delivery and transformation of cells. His work is instrumental in advancing therapeutic techniques that can potentially treat various disorders.
Latest Patents
Changyu Zheng's latest patents include groundbreaking inventions such as a hybrid adeno-retroviral vector for the transfection of cells. This invention involves an adenovirus that incorporates adenoviral capsid proteins and a replication-defective adenoviral vector. The vector includes essential components such as retroviral LTR nucleic acid sequences and a transgene, which are crucial for effective gene delivery. Another notable patent is the hybrid adenoviral vector, which features two adenoviral ITRs flanking a packaging signal and a single retroviral LTR. This invention also provides methods for transforming cells and introducing transgenes, showcasing his innovative approach to gene therapy.
Career Highlights
Changyu Zheng is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this esteemed institution allows him to collaborate with leading researchers and contribute to significant advancements in medical science. His expertise in gene therapy has positioned him as a key figure in the field.
Collaborations
Some of Changyu Zheng's notable coworkers include Brian Christopher O'Connell and Bruce J Baum. Their collaborative efforts enhance the research environment and foster innovation in gene therapy.
Conclusion
Changyu Zheng's work exemplifies the spirit of innovation in the field of gene therapy. His patents and contributions are paving the way for new therapeutic strategies that hold promise for treating various medical conditions.